Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1609 | 714 | 0.1063 | 0.1023 | 0.4438 | 0.4297 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 664 | 293 | 0.2841 | 0.2946 | 0.4413 | 0.4049 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1470 | 646 | 0.1366 | 0.1323 | 0.4395 | 0.4743 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1602 | 701 | 0.2735 | 0.2031 | 0.4376 | 0.4582 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1148 | 502 | 0.1493 | 0.1445 | 0.4373 | 0.4584 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 3 | 1432 | 626 | 0.0615 | 0.0676 | 0.4372 | 0.4031 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 414 | 180 | 0.1442 | 0.1471 | 0.4348 | 0.4142 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 3 | 1975 | 853 | 0.2574 | 0.2144 | 0.4319 | 0.4251 |
WM-115 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1516 | 654 | 0.2471 | 0.2677 | 0.4314 | 0.4255 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 1.000 | uM | 72 | hr | 2 | 1817 | 782 | 0.3175 | 0.3130 | 0.4304 | 0.4335 |
WM-115 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 3 | 1841 | 792 | 0.2653 | 0.2705 | 0.4302 | 0.4169 |
COLO 858 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 2 | 1114 | 477 | 0.1462 | 0.1426 | 0.4282 | 0.3974 |
WM-115 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1701 | 727 | 0.2792 | 0.2677 | 0.4274 | 0.4255 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 2179 | 931 | 0.1482 | 0.1578 | 0.4273 | 0.3985 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1784 | 762 | 0.1213 | 0.1083 | 0.4271 | 0.4526 |
WM-115 | Vemurafenib | I-BET | 1.000 | 1.000 | uM | 72 | hr | 3 | 1611 | 687 | 0.2651 | 0.3008 | 0.4264 | 0.4036 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1420 | 605 | 0.1381 | 0.1369 | 0.4261 | 0.4519 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1666 | 709 | 0.1136 | 0.1023 | 0.4256 | 0.4297 |
COLO 858 | Vemurafenib | I-BET | 1.000 | 0.000 | uM | 72 | hr | 3 | 1357 | 576 | 0.2388 | 0.1880 | 0.4245 | 0.4335 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1513 | 641 | 0.1246 | 0.1453 | 0.4237 | 0.3955 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 1576 | 666 | 0.2272 | 0.2193 | 0.4226 | 0.3870 |
WM-115 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1300 | 547 | 0.2158 | 0.2243 | 0.4208 | 0.4138 |
A-375 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 2 | 1407 | 591 | 0.0623 | 0.0484 | 0.4200 | 0.5323 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1265 | 531 | 0.0871 | 0.1023 | 0.4198 | 0.4297 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 625 | 262 | 0.2237 | 0.2820 | 0.4192 | 0.3755 |